Table 1.
Source | Method | Group | Totals | HLHS | CoA | AVS/BAV | LSL + ASD |
---|---|---|---|---|---|---|---|
Hitz 2012 [12] (a) | Affymetrix SNP | Multiplex families | 59 | ||||
Array 6.0 | Trios | 8 | |||||
| |||||||
Payne 2012 [14] (a) | All Cases | 43 | 43 | ||||
Syndromic cases | 10 | 10 | |||||
| |||||||
Geng 2014 [25] (b) | Agilent 244K | CHD Cases (multiple types) | 410 | 47 | 74 | ||
Isolated CHD cases | 31 | 26 | |||||
Syndromic CHD cases | 248 | 16 | 48 | ||||
Pathogenic CNV Isolated cases | 162 | 5 | 5 | ||||
Pathogenic CNV Isolated and Syndromic Cases | 8 | 19 | |||||
| |||||||
White 2014 [25] | HumanHap550 V3 | CHD Cases (multiple types) | 257 | 122 | 83 | 51 | |
Pathogenic Inherited CNV All cases (c) | 68 | ||||||
Pathogenic de novo CNV All Cases (c) | 5 | ||||||
| |||||||
Glessner 2014 [10](d) | Omni 1M | CHD cases SNP genotype array (multiple types) | 415 | 60 | 97 | 204 | |
WES | CHD cases WES | 358 | 46 | 65 | 146 | ||
CHD Cases by Both methods | 233 | ||||||
Pathogenic de novo CNV All Cases | 11 | 6 | 5 | ||||
Pathogenic de novo CNV cases (extracardiac lesions) | 3 | 3 | 3 | ||||
| |||||||
Warburton 2014 [18] | Nimblegen HD2 | CHD Cases (Conotruncal and HLHS) | 223 | 71 | |||
Pathogenic de novo CNV All Cases | 9 |
- CNV pathogenicity not defined, therefore CNVs not included
- No parental testing; CoA group includes CoA, AS, and "other"
- large CNVs (>269 kb)
– No differentiation between isolated and extracardiac; de novo events in isolated stated at 6% and in extracardiac at 31%